Table 2.
Modality | Hematoma | Contusion | SAH | DAI | Ischemia | Vasospasm |
---|---|---|---|---|---|---|
CT | +++ | ++ | +++ | +/0 | +/0 | 0 |
CTA | 0 | 0 | + | 0 | + | +++ |
CTP | + | + | 0 | 0 | ++ | ++ |
T2 FLAIR | + | +++ | +++ | + | + | 0 |
1.5T T2* GRE | + | + | +++ | + | 0 | 0 |
3T T2* GRE | + | + | +++ | ++ | 0 | 0 |
SWI | +++ | ++ | ++ | +++ | 0 | 0 |
DTI | + | + | 0 | +++ | +++ | 0 |
PWI | + | + | 0 | + | ++ | ++ |
MRSI | 0 | 0 | 0 | ++ | + | 0 |
MRA | 0 | 0 | + | 0 | ++ | +++ |
fMRI | 0 | 0 | 0 | ? | 0 | 0 |
PET | 0 | + | 0 | ? | +++ | 0 |
Scoring: little/no data, ?; insensitive, 0; minimally sensitive, +/0; mildly sensitive, +; moderately sensitive + +; highly sensitive, + + +.
CT, computed tomography; CTA, computed tomography angiography; CTP, computed tomography perfusion; DAI, diffuse axonal injury; DTI, diffusion tensor imaging; fMRI, blood oxygenation level dependent (BOLD) functional magnetic resonance imaging; MRA, 3D time-of-flight MR angiography; MRSI, MR spectroscopic imaging; PET, positron emission tomography; PWI, dynamic susceptibility contrast perfusion-weighted imaging; SAH, subarachnoid hemorrhage; SWI, susceptibility-weighted imaging; T2 FLAIR, T2-weighted fluid attenuated inversion recovery; T2*GRE, T2*-weighted gradient echo.